Personal tools
Dr. John Roder
You are here: Home Researchers Dr. John Roder

roder  

Dr. John Roder 
SENIOR INVESTIGATOR

Dr. John Roder is a neurobiologist, and Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital. As a Professor in the Department of Molecular Genetics at the University of Toronto, Dr. Roder holds a Canada Research Chair (Tier 1) in Learning and Memory.


Dr. Roder’s ultimate goal is to discover new treatments for schizophrenia, anxiety, epilepsy, depression, and other mental disorders.


His research focuses on the roles of molecules in the central nervous system and aims to determine targeted new drug therapies for neurological and psychiatric disease. He has carried out genome-wide forward and reverse genetic screens of ENU mutagenized mice. T
he Roder lab is also focused on identifying new genes, synapse and signaling pathways that contribute to learning and memory.


In a groundbreaking study in 2007, Dr. Roder demonstrated for the first time in mouse models that malfunction of the gene DISC 1, previously associated with schizophrenia and depression, does, in fact, cause symptoms of those disorders.

 

 
Samuel Lunenfeld
Research Institute
Mount Sinai Hospital
Joseph & Wolf Lebovic Health Complex
600 University Avenue
Toronto Ontario M5G 1X5

Tel: 416-586-8241
► Send Email
► Lab Website
► Neurobehaviour Website 

Jul 15, 2009 04:50 PM

At a Glance

  • Ultimate goal is to discover new treatments for schizophrenia, anxiety, epilepsy, depression and other mental disorders
  • Holds a Canada Research Chair in Learning and Memory
  • Researches the roles of molecules in the central nervous system

 

Major Research Activities

Dr. Roder is exploring the link between long ­term potentiation (LTP), synaptic and learning and memory using engineered mice that lack the glutamate receptors. His lab is focusing on the steps of the complex cascade of events that lead to LTP. Specifically, the Roder lab is examining the means by which NMDA, AMPA and metabotropic glutamate receptors, and their downstream signalling cascades, act to regulate synaptic strength.

 

Recent Publications

Clapcote, S.J., Duffy, S., Xie, G., Kirshenbaum, G., Bechard, A.R., Schack, V.R., Petersen, J., Sinai, L., Saab, B.J., Lerch, J.P., Minassian, B.A., Ackerley, C.A., Sled, J.G., Cortez, M.A., Henderson, J.T., Vilsen, B., RODER, J.C. Inactivation of Na+,K+-ATPase ?3 Causes Epilepsy in Mice. (Accepted 2009, PNAS).

Labrie, V., Fukumura, R., Rastogi, A., Fick, L.J., Wang, W.,  Boutros, P.C., Kennedy, J.L., Semeralul, M.O., Lee, F.H., Baker, G.B., Belsham, D.D., Barger, S.W., Gondo, Y., Wong, A.H.C., and RODER J.C. (2009) Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Human Molecular Genetics (In Press).

Saab, B., Georgiou, J., Nath, A., Lee, F.J.S., Michalon, A., Liu, F., Mansuy, I., and RODER J.C. Ncs1 in the Dentate Gyrus Regulates D2R Surface Expression, Synaptic Plasticity, Memory and Curiosity (Accepted pending changes 2009, Neuron).

Clapcote, S.J., Duffy, S., Xie, G., Kirshenbaum, G., Bechard, A.R., Schack, V.R., Petersen, J., Sinai, L., Saab, B.J., Lerch, J.P., Minassian, B.A., Ackerley, C.A., Sled, J.G., Cortez, M.A., Henderson, J.T., Vilsen, B., RODER, J.C. Inactivation of Na+,K+-ATPase a3 Causes Epilepsy in Mice. (August 2009, PNAS).

Lipina, T., RODER, J.C. New model of the disrupted Latent Inhibition induced by Bupropion. (Accepted 2009, Psychopharmacology).

Labrie, V., Fukumura, R., Rastogi, A., Fick, L.J., Wang, W.,  Boutros, P.C., Kennedy, J.L., Semeralul, M.O., Lee, F.H., Baker, G.B., Belsham, D.D., Barger, S.W., Gondo, Y., Wong, A.H.C., and RODER J.C. (2009) Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Human Molecular Genetics (In Press).

Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, RODER JC. (2007). Behavioral phenotypes of Disc1 missense mutations in mice. Neuron. May 3;54(3):387-402.

Reviewed by Marx J. (2007). Behavioral genetics. Evidence linking DISC1 gene to mental illness builds. Science. Nov 16;318(5853):1062-3.

Labrie, V., Duffy, S., Wang, W., Barger, S.W., Baker, G.B., RODER, J.C. (2009). Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice. Learning and Memory (Cover page). 16: 28-37.

Tsujimoto, T., Jeromin A., Saitoh N., RODER J.C., Takahashi T. (2002). Neuronal Calcium Sensor 1 and Activity-Dependent Facilitation of P/Q-type Calcium Currents at Presynaptic Nerve Terminals. Science, March 22, 295 (5563):2276-2279.

 

► Lunenfeld Research Repository

 

 

Document Actions
Ontario Health Study Faculty of Medicine, University of Toronto. stay connected with the lunenfeld
twitterfacebookyoutube[RSS]

 

 
plone python css browser compatibility any
       
 
   
spinner